Mar 6, 2024, 08:25 by

Lindus Health Launches “All-In-One Metabolic CRO” Offering to Accelerate and Enhance Metabolic Clinical Trials

Mar 6, 2024, 05:00 by User Not Found

Clinical Research News | If artificial intelligence (AI) is to be as insightful as possible in advancing human health, it is not enough to have a patchwork of out-of-context data from which to draw conclusions. That is unfortunately the current situation and at the cost of lost opportunities to better treat patients, identify early biomarkers of disease, and recognize the right endpoints in clinical trials—not to mention eradicating existing biases against marginalized groups of people.

Mar 5, 2024, 08:43 by

WCG’s Statistical Consulting Solutions empower biotechnology firms, CROs, pharmaceutical companies, medical device manufacturers, government agencies, and non-profit organizations with comprehensive statistical support across all stages of clinical trial design and regulatory strategy.

Mar 5, 2024, 08:43 by

Synexa Life Sciences has announced the integration of the Olink® Target immunoassays and the Olink® Signature Q100 instrument into its extensive suite of biomarker discovery platforms.

Mar 5, 2024, 01:00 by User Not Found

Clinical Research News | Decentralized clinical trials (DCTs) today are both more fit-for-purpose and business-as-usual than uncertain and unavoidable, as was the case during the height of the COVID-19 pandemic. Among the key challenges with DCTs are keeping sites and patients engaged, dealing with the near-constant inflow of data from digital platforms and wearable devices, and quantifying the value of various decentralized study components.

Feb 29, 2024, 08:52 by

Feb 29, 2024, 08:52 by

Feb 29, 2024, 08:52 by

Feb 29, 2024, 01:00 by User Not Found

Clinical Research News | Medidata and Sanofi Vaccines announced a collaboration to harness Medidata eCOA to deploy in vaccine studies; H1 has launched GenosAI Pro, a new addition to its conversational AI toolkit within Trial Landscape platform; and more.

Feb 28, 2024, 07:35 by

Feb 28, 2024, 07:35 by

Feb 28, 2024, 07:35 by

Feb 28, 2024, 07:35 by

Univo IRB was announced as the new company name for Principal IRB.

Feb 28, 2024, 07:35 by

PathAI, Inc., a leading AI-powered precision pathology company, today announced the availability of two new features on the AISight digital pathology image management system – an Intelligent Caselist and AISight Live.

Feb 28, 2024, 01:00 by User Not Found

Clinical Research News | Circular Genomics plans to build and scale commercial operations in preparation for the launch of the world's first circular RNA-based clinical assay; NextPoint Therapeutics will advance the company’s two immuno-oncology clinical programs, NPX267 and NPX887; Accent Therapeutics will use funding to support the advancement of both lead programs—Accent’s first-in-class DHX9 inhibitor and a potentially best-in-class KIF18A inhibitor; and more.

Feb 27, 2024, 16:29 by User Not Found

Clinical Research News | If artificial intelligence (AI) is to be as insightful as possible in advancing human health, it is not enough to have a patchwork of out-of-context data from which to draw conclusions. That is unfortunately the current situation and at the cost of lost opportunities to better treat patients, identify early biomarkers of disease, and recognize the right endpoints in clinical trials—not to mention eradicating existing biases against marginalized groups of people.

Feb 27, 2024, 08:20 by

Feb 27, 2024, 08:20 by

Feb 27, 2024, 08:20 by

Pelago Biosciences has announced that the University of Edinburgh has acknowledged its Cellular Thermal Shift Assay (CETSA®) patent and use thereof in selected works in drug discovery research.

Feb 27, 2024, 08:20 by

Elligo Health Research announces a new collaboration with Ireland-based WHYZE Health.